Actively Recruiting

Age: 6Years +
All Genders
NCT07127978

A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy

Led by ITF Therapeutics LLC · Updated on 2026-04-15

300

Participants Needed

7

Research Sites

248 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a prospective observational study conducted to evaluate safety, tolerability, and functional outcomes of patients with DMD newly initiating oral givinostat or having started therapy within 6 months as part of routine clinical care in the US. The study has a planned maximum duration of 5 years for the first enrolled patients, including a 24-month enrollment period and a minimum of 2 years of follow-up.

CONDITIONS

Official Title

A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy

Who Can Participate

Age: 6Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients of any gender at least 6 years of age, diagnosed with DMD (according to genetic test) and have received a prescription for oral givinostat in accordance with the USPI.
  • Patient has provided informed consent (and assent when applicable) for participation in the study.
  • Patient's index date (first date of givinostat treatment) is no more than 6 months prior to signing of informed consent.
  • Patient has the required data available (DMD diagnosis, givinostat administration [dose and schedule], laboratory results [hematology and triglycerides]) for addressing the study objectives for the period between index date and study entry (for patients enrolled after the index date).
Not Eligible

You will not qualify if you...

  • Patient previously received givinostat (commercial or investigational product) and permanently discontinued treatment.
  • Patient started commercial givinostat for > 6 months before signing of informed consent.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 7 locations

1

Arkansas Children's Research Institute

Little Rock, Arkansas, United States, 72202

Actively Recruiting

2

Children's National Hospital

Washington D.C., District of Columbia, United States, 20010

Actively Recruiting

3

Ann and Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, United States, 60611

Actively Recruiting

4

Boston Children's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

5

University of Massachusetts Chan Medical School

Worcester, Massachusetts, United States, 01655

Actively Recruiting

6

Columbia University Medical Center

New York, New York, United States, 10032

Actively Recruiting

7

Seattle Children's Hospital

Seattle, Washington, United States, 98105

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here